💊 Methotrexate (Methotrexate)
Methotrexate Injection is a folate analog metabolic inhibitor given under medical supervision. It is used to treat several cancers (such as acute lymphoblastic leukemia and non-Hodgkin lymphoma), rheumatoid arthritis, and severe psoriasis. The dose and duration are set by your doctor according to your condition.
In Arabic: ميثوتريكسات🏷️ Brand names & manufacturers
Jylamvo🏭 SHORLA ONCOLOGY INC.DailyMed
Otrexup🏭 Antares Pharma, Inc.DailyMed
Xatmep🏭 Azurity Pharmaceuticals, Inc.DailyMed
Rasuvo🏭 Medexus Pharma Inc.DailyMed
Trexall🏭 Teva Women's Health LLCDailyMed
Methotrexate🏭 Alembic Pharmaceuticals Inc.DailyMed✅ What it is used for
- Acute lymphoblastic leukemia in adults and children as part of combination chemotherapy
- Prophylaxis and treatment of meningeal leukemia
- Non-Hodgkin lymphoma
- Osteosarcoma (as part of combination chemotherapy)
- Breast cancer in adults (as part of combination chemotherapy)
- Squamous cell carcinoma of the head and neck as a single agent
- Gestational trophoblastic neoplasia
- Rheumatoid arthritis in adults
- Polyarticular juvenile idiopathic arthritis in children
- Severe psoriasis in adults
🧪 Active ingredient
The active substance is methotrexate, which inhibits dihydrofolic acid reductase and thereby interferes with DNA synthesis, repair, and cellular replication. Rapidly proliferating tissues such as malignant cells and bone marrow are generally more sensitive.
🌿 Benefits
- Used as part of treatment for a range of cancers in adults and children
- Used to treat rheumatoid arthritis and polyarticular juvenile idiopathic arthritis
- Used to treat severe psoriasis
📝 How to use
- The injection is given intramuscularly, intravenously, subcutaneously, or intrathecally depending on the condition and formulation.
- The dose and schedule are determined only by the doctor or pharmacist and must not be changed on your own.
- For some conditions (such as rheumatoid arthritis and psoriasis) the dose is given once weekly; follow the schedule set by your doctor exactly.
- With intermediate- and high-dose regimens, your doctor may give intravenous fluids and leucovorin rescue and monitor blood and kidney tests.
- Take folic or folinic acid only as directed by your healthcare provider.
💊 Dosage forms
- Injection with preservative (multiple-dose vial): 50 mg/2 mL (25 mg/mL)
- Preservative-free injection (single-dose vial): 1 g/40 mL (25 mg/mL)
⚠️ Common side effects
- Ulcerative stomatitis
- Low white blood cell count (leukopenia)
- Nausea
- Abdominal distress
- Infection
- Malaise and fatigue
- Chills and fever
- Dizziness
- Elevated liver function tests
🚨 Serious — seek medical help
- Hypersensitivity reactions including anaphylaxis
- Myelosuppression and serious infections
- Renal toxicity
- Hepatotoxicity
- Neurotoxicity
- Gastrointestinal toxicity
- Pulmonary toxicity (e.g., interstitial pneumonitis)
- Serious dermatologic reactions
- Secondary malignancies
- Tumor lysis syndrome
- Deaths have been reported with methotrexate
⛔ Do not use if
- History of severe hypersensitivity to methotrexate
- Pregnancy in patients with non-neoplastic diseases
❗ Warnings & precautions
- Can cause embryo-fetal toxicity, including fetal death; verify pregnancy status before starting treatment.
- Females of reproductive potential should use effective contraception during treatment and for 6 months after the last dose; males with female partners of reproductive potential should do so during treatment and for 3 months after the last dose.
- Formulations with benzyl alcohol can cause severe central nervous system toxicity or metabolic acidosis; only preservative-free product should be used in neonates, low birth weight infants, and intrathecally.
- Close monitoring is needed for infections and adverse reactions of the bone marrow, kidneys, liver, nervous system, gastrointestinal tract, lungs, and skin; the doctor may withhold or discontinue treatment.
- Vaccines may be ineffective, and live vaccines are not recommended because of the risk of disseminated infection.
- May impair fertility, cause oligospermia, and menstrual dysfunction.
- Nitrous oxide anesthesia should be avoided in patients receiving methotrexate.
- Methotrexate is a hazardous drug requiring special handling and disposal.
🔄 Drug interactions
- Penicillin or sulfonamide antibiotics
- Highly protein-bound drugs (e.g., oral anticoagulants, phenytoin, salicylates, sulfonamides, sulfonylureas, tetracyclines)
- Proton pump inhibitors
- Probenecid
- Antifolate drugs (e.g., dapsone, pemetrexed, pyrimethamine)
- Aspirin and other NSAIDs (unexpectedly severe and fatal gastrointestinal toxicity can occur)
- Mercaptopurine
- Hepatotoxic, nephrotoxic, or hematotoxic products
- Imatinib and dasatinib
- Nitrous oxide (increases risk of severe reactions)
- Folic acid and derivatives (decrease effectiveness of methotrexate in neoplastic diseases)
- Theophylline (affected by methotrexate coadministration)
- Tell your doctor about all medicines you take.
🤰 Pregnancy
Contraindicated in pregnant patients with non-neoplastic diseases. Methotrexate can cause embryo-fetal toxicity and fetal death, and first-trimester exposure is associated with increased spontaneous abortions and multiple developmental abnormalities. In neoplastic diseases, pregnant women should be advised of the potential risk to the fetus, and preservative-free formulation should be used when possible. Pregnancy status must be verified before treatment and effective contraception used.
🍼 Breastfeeding
The label advises not to breastfeed during treatment.
🧒 Children
Safety and effectiveness have been established in children for ALL, meningeal leukemia prophylaxis and treatment, non-Hodgkin lymphoma, osteosarcoma, and pJIA. They have not been established for breast cancer, head and neck squamous cell carcinoma, gestational trophoblastic neoplasia, rheumatoid arthritis, or psoriasis. Only preservative-free product should be used in neonates and low birth weight infants because of the risk of fatal gasping syndrome. Intermediate-dose methotrexate can cause serious neurotoxicity in ALL patients.
👴 Older adults
Clinical studies did not include enough subjects aged 65 and over to determine whether they respond differently from younger subjects.
🌡️ Storage
Store at 20–25°C (excursions permitted to 15–30°C) and protect from light. After first puncture, store multiple-dose vials at 2–8°C and use within 30 days. It is a hazardous drug; follow special handling and disposal procedures.
⏰ Missed dose
Injections are given by a doctor or nurse; if you miss a scheduled dose, contact your doctor to arrange a new time and do not double the dose.
🆘 Overdose
Overdose can cause low blood cell counts, mucositis, stomatitis, nausea, vomiting, gastrointestinal ulceration or bleeding, and renal failure; intrathecal overdose can cause CNS symptoms such as headache and seizures. Leucovorin or levoleucovorin should be given as soon as possible, and glucarpidase may be used in selected cases. Seek emergency medical care immediately.
💰 Price & brands in your area
🏛️ Official price in Palestine — Ministry of Health price list:
| Product | Company | Pack | Price |
|---|---|---|---|
| ABITREXATE 50MG/2ML Methotrexate | Teva | 1 VIAL | 37 ₪ |
| Methotrexate 'ebewe' 2.5mg tablet Methotrexate 2.5mg | MASROUJI CO. | 50 Tab | 40 ₪ |
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Methotrexate inhibits dihydrofolic acid reductase, preventing formation of tetrahydrofolates needed for purine nucleotide and thymidylate synthesis, thereby interfering with DNA synthesis, repair, and cellular replication. Actively proliferating tissues (malignant cells, bone marrow, fetal cells, buccal and intestinal mucosa, urinary bladder cells) are more sensitive. The mechanism in RA, pJIA, and psoriasis is unknown. Distribution: initial volume ~0.18 L/kg, steady-state 0.4–0.8 L/kg, ~50% protein bound; does not penetrate the blood-CSF barrier in therapeutic amounts via IV, IM, or SC routes. Terminal half-life is 3–10 hours (psoriasis, RA, low-dose antineoplastic therapy) and 8–15 hours after high-dose IV. Undergoes hepatic and intracellular metabolism to polyglutamated forms.
Labeled dosing
General adult dosing per the label: RA: starting dose 7.5 mg once weekly intramuscularly, adjusted for optimal response. Psoriasis: 10–25 mg once weekly intramuscularly or intravenously, reduced to the lowest effective dose once response is achieved. ALL: part of a multi-drug regimen, 10 to 5000 mg/m² intravenously (lower doses, e.g., 20–30 mg/m² weekly, may be given intramuscularly). Other neoplastic diseases follow disease-specific dosing in the full prescribing information. The actual dose is set by the doctor or pharmacist.
- Verify pregnancy status in females of reproductive potential before starting.
- Use only preservative-free product in neonates, low birth weight infants, and for intrathecal use.
- Administer leucovorin rescue with doses ≥500 mg/m²; consider with doses 100 to <500 mg/m².
- For high-dose regimens: monitor serum creatinine and electrolytes at baseline and at least daily, give IV fluids, alkalinize urine to pH ≥7, and monitor methotrexate concentrations at least daily.
- Give glucarpidase for toxic plasma concentrations (>1 micromole/L) with delayed clearance due to renal impairment; do not give leucovorin within 2 hours before or after glucarpidase.
- When switching between oral and injectable forms, consider differences in bioavailability.
- Neither hemodialysis nor peritoneal dialysis has been shown to improve methotrexate elimination.
🎓 Key points for students
- Methotrexate is a folate analog metabolic inhibitor that inhibits dihydrofolate reductase.
- It most affects rapidly dividing cells: malignant cells, bone marrow, and mucosal tissues.
- Boxed warning: embryo-fetal toxicity, hypersensitivity, benzyl alcohol toxicity, and other serious reactions.
- Preservative-free formulation is required for intrathecal use and in neonates.
- Leucovorin rescues from toxicity; glucarpidase is used for delayed renal clearance with toxic levels.
- Key interactions: NSAIDs, nitrous oxide, sulfonamides, proton pump inhibitors, probenecid.
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What is methotrexate injection used for?
It is used to treat several cancers such as acute lymphoblastic leukemia, non-Hodgkin lymphoma, and osteosarcoma, as well as rheumatoid arthritis, juvenile idiopathic arthritis in children, and severe psoriasis.
Can it be used during pregnancy?
No. It is contraindicated in pregnancy for non-neoplastic diseases because it can cause fetal death and birth defects. Effective contraception is required during and after treatment for the periods stated in the label.
What are the most common side effects?
Ulcerative stomatitis, low white blood cell count, nausea, and abdominal distress. Infection, fatigue, fever, and dizziness are also frequently reported.
Should I take folic acid with it?
Take folic or folinic acid only as directed by your healthcare provider, as it can reduce methotrexate's effectiveness in cancer treatment.
Can I breastfeed during treatment?
The label advises not to breastfeed during methotrexate treatment.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2026-10), simplified. Updated: 2026-11-15.